Willis Expands Leadership Team in North America NEW YORK,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Willis Expands Leadership Team in North America

NEW YORK, Jan. 8, 2014 (GLOBE NEWSWIRE) -- Willis North America (WNA), a unit of Willis Group Holdings (NYSE: WSH ), the global risk advisor, insurance and reinsurance broker, today announced a revised organizational structure and a series of related senior appointments that are designed to strengthen the firm's service to its clients, align its resources toward that goal and, in the process, drive growth throughout the business.

WNA is the North American retail brokerage business of Willis Group Holdings and the company's largest business segment. The business, which in 2012 reported revenues of more than $1.3 billion, includes more than 100 local offices across the United States and Canada offering a full range of insurance and risk management services, specialist expertise and global resources to clients in every sector.

WNA's new organizational structure will include the following seven regions – Northeast, Atlantic, South, Midwest, West, California and Canada – supported by a corresponding team of National Partners. This evolution in North America's structure reflects the unique opportunities within various geographies and better positions WNA to bring the full breadth of Willis' expertise and capabilities to clients in each of its local offices.

The appointments announced today, all of whom will report to Todd Jones, CEO, WNA, include the following:

Eric Hein has been appointed National Partner of the South Region. He will be responsible for the region's business operations, which includes 500 Associates in 15 offices throughout Alabama, Florida, Georgia, Louisiana and the Carolinas. Hein joined Willis in 1985 and has held a variety of leadership roles. Since 1999 he served as Managing Partner of Willis' North and South Carolina operations where, under his leadership, Willis established itself as a market leader in the Carolinas. He is based in Charlotte, NC.

KJ Wagner has been appointed National Partner of the West Region. He will be responsible for the region's business operations, which includes 675 Associates in 10 offices throughout Arizona, Colorado, Texas, Oklahoma, Oregon, Washington and Wyoming. Wagner joined Willis in 1999 and most recently served as Managing Partner, Willis of Arizona, since 2008. Previously Wagner served as one of Willis' top producers in North America where he focused on risk transfer programs for large firms with complex risks. He is based in Scottsdale, AZ.

David Fuhrman has been appointed National Partner of the newly established California Region. He will be responsible for the region's business operations, which includes 365 Associates throughout offices in Los Angeles, Irvine, Sacramento, San Diego, San Jose and San Francisco. Fuhrman joined Willis in 2005 and previously served as Managing Partner, Willis of Los Angeles. Under his leadership, Willis of Los Angeles established itself as a top performing operation in North America. He is based in Los Angeles, CA.

Hein, Wagner and Fuhrman will work closely with the existing regional leadership team including Joe Gunn, National Partner of the Northeast Region; Doug Pera, National Partner of the Atlantic Region; Mike Liss, National Partner of the Midwest Region and Rick Hynes, National Partner of Canada.

Commenting on the appointments, Todd Jones said, "We are thrilled to welcome Eric, KJ and David to the leadership team. They each bring strong track records of success in driving high levels of client satisfaction and business results and we look forward to continuing the organic growth we have achieved in recent quarters in North America."

To further support its North America platform, Willis today announced several additional appointments, including:

Paty Daves has been appointed Managing Partner, Willis of Illinois. In this role, he will oversee business operations in Willis' Chicago, Schaumburg and Moline offices as supported by a staff of more than 400 Associates. Since 2008, Daves served as Managing Partner, Willis of Kansas. He will be based in Chicago and report to Mike Liss.

John Sherlock has been appointed Managing Partner, Willis of Pennsylvania. In this role, he will oversee business operations in Willis' Philadelphia and Radnor offices as supported by a staff of more than 200 Associates. Sherlock joined Willis from Philadelphia Insurance Company where he served as Senior Vice President responsible for large broker strategy. Prior to this, Sherlock was with AIG where he served as president of the Mid-Atlantic region. He is based in Philadelphia, PA and will report to Doug Pera.

About Willis

Willis Group Holdings plc is a leading global risk advisor, insurance and reinsurance broker. With roots dating to 1828, Willis operates today on every continent with more than 17,500 employees in over 400 offices. Willis offers its clients superior expertise, teamwork, innovation and market-leading products and professional services in risk management and transfer. Our experts rank among the world's leading authorities on analytics, modelling and mitigation strategies at the intersection of global commerce and extreme events. Find more information at our website, www.willis.com , our leadership journal, Resilience , or our up-to-the-minute blog on breaking news, WillisWire . Across geographies, industries and specialisms, Willis provides its local and multinational clients with resilience for a risky world.

Media: Colleen McCarthy +1 212 915 8307 Investors: Peter Poillon +1 212 915 8084

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 266

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 208

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 33

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 0

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 164

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 284

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 171

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 208

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Precious Metals and Energy Investors' Strategies

Updated Category News Views 143

Current Trends in Precious Metals The appeal of precious metals like gold and silver continues to gather momentum, particularly in light of recent global events. Many analysts believe that geopolitical tensions have created a catalyst for increased interest in gold as a safe haven. As governments grapple with economic challenges, investors are keenly observing changes in...

Continue Reading
Understanding P/E Ratios in the Context of Casey's General Stores

Updated Category News Views 175

Analyzing P/E Ratios for Investment Decisions In today’s market, understanding the performance metrics of stocks is vital. Currently, Casey's General Stores Inc. (NASDAQ: CASY) is noted at an impressive share price of $536.66. This reflects a modest increase of 0.33%. In examining market trends, the past month saw a slight decline of 4.39% in share value. However,...

Continue Reading
China's New Lending Outlook: Economic Recovery Strategies

Updated Category News Views 135

China's Recent New Lending Trends Recent updates reveal a significant rise in new bank lending in China. However, it didn't quite meet expectations, as analysts had hoped for a stronger performance. After disappointing figures in July, which hit a 15-year low, new data shows that Chinese banks issued around 900 billion yuan (approximately $126.86 billion) in new loans in...

Continue Reading
ParkOhio Shares Important Quarterly Dividend News for Investors

Updated Category News Views 177

ParkOhio Holdings Announces Latest Dividend Declaration Park-Ohio Holdings Corp. (NASDAQ: PKOH) recently declared a significant quarterly cash dividend of $0.125 per share to its common stockholders. This distribution demonstrates the company's ongoing commitment to providing returns to its shareholders. This dividend will be payable soon, marking another positive...

Continue Reading
Investigation Launched for Tourmaline Bio's Shareholders

Updated Category News Views 259

Investigation Overview on Tourmaline Bio, Inc. Recently, Monteverde & Associates PC, a renowned law firm, has initiated an investigation concerning Tourmaline Bio, Inc. (NASDAQ: TRML) and its proposed sale to Novartis AG. This potential acquisition raises several questions about the fairness of the deal, specifically regarding the cash payment offered to shareholders....

Continue Reading